Table 8 Clinical characteristics of patients in the immunotherapy and control groups

Age (years)

38.89 ± 16.60

47.84 ± 19.66

0.129

Gender (M,%)

7.0 (36.8)

12.0 (63.2)

0.105

Epilepsy duration, y

[M (P₂₅,P₇₅)]

3.0 (2.0,7.0)

2.0 (1.0,4.0)

0.230

Age at first seizure, y

[M (P₂₅,P₇₅)]

31.0 (20.0, 47.0)

48.0 (30.0, 57.0)

0.129

Abnormal EEG (n, %)

15.0 (78.9)

17.0 (89.5)

0.374

Abnormal MRI (n, %)

12.0 (63.2)

15.0 (78.9)

0.283

Number of AEDs

2.16 ± 0.50

2.21 ± 0.42

0.433